AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2010

Apr 28, 2010

34023_dirs_2010-04-28_b79ae7a7-4d2c-43e7-8413-abe1adc5377f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANTIGENICS INC /DE/ (AGEN)
CIK: 0001098972
Period of Report: 2010-04-26

Reporting Person: Sharp Shalini (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-04-26	Common Stock	A	3750	$1.19	Acquired	240818	Direct
2010-04-27	Common Stock	S	1950	$1.1601	Disposed	238868	Direct

Footnotes

F1: Represents settlement of restricted stock awarded on January 26, 2010.

F2: Represents only shares sold to cover minimum federal, state, and local tax withholding requirements upon the vesting of the restricted shares awarded on January 26, 2010. This sale was made through a Rule 10b5-1 trading plan.